[PDF][PDF] Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients
Journal of Clinical Oncology, 2006•iris.unife.it
Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage
II and III Colorectal Cancer Patients Page 1 Immunohistochemical Test for MLH1 and MSH2
Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients Giovanni
Lanza, Roberta Gafa`, Alessandra Santini, Iva Maestri, Laura Guerzoni, and Luigi Cavazzini A
B S T R A C T Purpose To evaluate the prognostic significance of DNA mismatch repair (MMR)
status in a large series of stage II and III colorectal cancer patients. The relationship among …
II and III Colorectal Cancer Patients Page 1 Immunohistochemical Test for MLH1 and MSH2
Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients Giovanni
Lanza, Roberta Gafa`, Alessandra Santini, Iva Maestri, Laura Guerzoni, and Luigi Cavazzini A
B S T R A C T Purpose To evaluate the prognostic significance of DNA mismatch repair (MMR)
status in a large series of stage II and III colorectal cancer patients. The relationship among …
Purpose
To evaluate the prognostic significance of DNA mismatch repair (MMR) status in a large series of stage II and III colorectal cancer patients. The relationship among MMR status, adjuvant chemotherapy, and clinical outcome was also investigated.
iris.unife.it